Addressing the public health burden of respiratory viruses: the battle against respiratory viruses (BRaVe) initiative
Date
2013
Type:
Artículo
item.page.extent
1
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Future Medicine
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical management across different populations and resource settings. New therapeutics and specific vaccines for noninfluenza respiratory virus infections could provide enormous benefits in reducing the morbidity and mortality associated with these frequent infections and provide the foundation for responding to newly emerging threats. The BRaVe Initiative is a new WHO-led effort to catalyze multidisciplinary research on strategies to prevent and treat medically important respiratory virus infections with the goal of timely integration of scientific advances and technical innovations into public health practice.
Description
Centro de Epidemiología y Políticas de Salud
item.page.coverage.spatial
item.page.sponsorship
Citation
Future Virology, 2013, 8 (10): 953-968
Keywords
antivirals, emerging respiratory viruses, influenza virus, pneumonia, public health policies, respiratory syncytial virus, respiratory viral infections, severe acute respiratory infection, vaccines, WHO research agenda